Sign in

No death linked to Covid-19 vaccine in the country: Health ministry

As per the Union health ministry data, 6.8 million healthcare and frontline workers have been vaccinated till today with about 200,000 beneficiaries vaccinated on Wednesday.

Published on: Feb 11, 2021, 06:41:37 IST
By , New Delhi
Share
Share via
  • facebook
  • twitter
  • linkedin
Copy link
  • copy link

India’s death rate among individuals who received the Covid-19 vaccine is one of the lowest in the world. With 23 deaths reported in persons post immunisation till date, the percentage of deaths of the total vaccinations is as low as 0.0003%, shows government data released on Wednesday.

A file photo of a nurse displaying a vial of Covishield, the AstraZeneca Covid-19 vaccine manufactured by Serum Institute of India, at a medical centre in Mumbai, India. (REUTERS) (HT_PRINT)
A file photo of a nurse displaying a vial of Covishield, the AstraZeneca Covid-19 vaccine manufactured by Serum Institute of India, at a medical centre in Mumbai, India. (REUTERS) (HT_PRINT)

Of the 23 deaths, nine persons died in the hospital while 14 deaths are recorded outside the hospital. The government has maintained that none of the deaths have been casually linked to Covid-19 vaccination, highlighting the fact that both the vaccines approved for use in India are supremely safe. “There is no doubt about it that both the vaccines are very safe. The adverse reactions are as low as one in 14, which is miniscule in comparison,” said Dr VK Paul, member (health), Niti Aayog.

As per the Union health ministry data, 6.8 million healthcare and frontline workers have been vaccinated till today with about 200,000 beneficiaries vaccinated on Wednesday.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More